Last updated: 3 months ago
AstraZeneca PLC's March 2025 6-K Filing: Governance & Growth Insights
Explore AstraZeneca's March 2025 6-K filing analysis, focusing on corporate governance, dividend stability, board appointments, and market challenges. Recommendation: Hold.